
Er-Kim announces agreement with Immunocore
Er-Kim, an international pharmaceutical company specialising in the commercialisation of novel therapies, has announced that they have been appointed by Immunocore as the distribution and commercialisation partner for KIMMTRAK, for the treatment of HLA-A* …